This story has been updated from a previous version to include comments from Bio-Rad's earnings call.

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories reported after the close of the market today a 5 percent increase in fourth quarter revenues, driven by high-single-digit growth for its Life Science business.

The Hercules, Calif.-based company reported $602.6 million in revenues for the three months ended Dec. 31, 2013, up from $573.8 million a year ago, easily surpassing the average analyst estimate of $586.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.